STERIS (NYSE:STE) reported a stronger fiscal 2026 overall despite a lighter fourth quarter, with executives pointing to record annual revenue, resilient procedure demand and continued pricing gains, while also outlining expectations for mid- to high-single-digit growth in fiscal 2027.
Senior Vice President and CFO Karen Burton said fourth-quarter revenue grew 7% as reported, while constant currency organic revenue increased 5%, driven by volume and 230 basis points of pricing. Gross margin was 44%, down 30 basis points from the prior year, as positive pricing helped offset higher tariffs and inflation.
